| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Oncology,*
Pathology,
and
Urology,
The Johns Hopkins University School
of Medicine, Baltimore, Maryland
GSTP1 CpG island hypermethylation is the most common somatic genome alteration described for human prostate cancer (PCA); lack of GSTP1 expression is characteristic of human PCA cells in vivo. We report here that loss of GSTP1 function may have been selected during the pathogenesis of human PCA. Using a variety of techniques to detect GSTP1 CpG island DNA hypermethylation in PCA DNA, we found only hypermethylated GSTP1 alleles in each PCA cell in all but two PCA cases studied. In these two cases, CpG island hypermethylation was present at only one of two GSTP1 alleles in PCA DNA. In one of the cases, DNA hypermethylation at one GSTP1 allele and deletion of the other GSTP1 allele were evident. In the other case, an unmethylated GSTP1 allele was detected, accompanied by abundant GSTP1 expression. GSTP1 CpG island DNA hypermethylation was responsible for lack of GSTP1 expression by LNCaP PCA cells: treatment of the cells with 5-azacytidine (5-aza-C), an inhibitor of DNA methyltransferases, reversed the GSTP1 promoter DNA hypermethylation, activated GSTP1 transcription, and restored GSTP1 expression. GSTP1 promoter activity, assessed via transfection of GSTP1 promoter-CAT reporter constructs in LNCaP cells, was inhibited by SssI-catalyzed CpG dinucleotide methylation. Remarkably, although selection for loss of GSTP1 function may be inferred for human PCA, GSTP1 did not act like a tumor suppressor gene, as LNCaP cells expressing GSTP1, either after 5-aza-C treatment or as a consequence of transfection with GSTP1 cDNA, grew well in vitro and in vivo. Perhaps, GSTP1 inactivation may render prostatic cells susceptible to additional genome alterations, caused by electrophilic or oxidant carcinogens, that provide a selective growth advantage.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Moyer, O. E. Salavaggione, T.-Y. Wu, I. Moon, B. W. Eckloff, M. A.T. Hildebrandt, D. J. Schaid, E. D. Wieben, and R. M. Weinshilboum Glutathione S-Transferase P1: Gene Sequence Variation and Functional Genomic Studies Cancer Res., June 15, 2008; 68(12): 4791 - 4801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hokaiwado, F. Takeshita, A. Naiki-Ito, M. Asamoto, T. Ochiya, and T. Shirai Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells Carcinogenesis, June 1, 2008; 29(6): 1134 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T M Murphy, A S Perry, and M Lawler The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 11 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Huang, L. Mills, and L. L. Worth Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells Mol. Cancer Ther., May 1, 2007; 6(5): 1610 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakai, W. G. Nelson, and A. M. De Marzo The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine Acts as Both a Tumor Initiator and Promoter in the Rat Ventral Prostate Cancer Res., February 1, 2007; 67(3): 1378 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S Perry, R. Foley, K. Woodson, and M. Lawler The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr. Relat. Cancer, June 1, 2006; 13(2): 357 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Obligacion, M. Murray, and I. Ramzan Drug-Metabolizing Enzymes and Transporters: Expression in the Human Prostate and Roles in Prostate Drug Disposition J Androl, March 1, 2006; 27(2): 138 - 150. [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Vanaja, K. V. Ballman, B. W. Morlan, J. C. Cheville, R. M. Neumann, M. M. Lieber, D. J. Tindall, and C. Y.F. Young PDLIM4 Repression by Hypermethylation as a Potential Biomarker for Prostate Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1128 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Lee, S. Yegnasubramanian, X. Lin, and W. G. Nelson Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1 J. Biol. Chem., December 9, 2005; 280(49): 40749 - 40756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson Prostate carcinogenesis and inflammation: emerging insights Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Valinluck, P. Liu, J. I. Kang Jr, A. Burdzy, and L. C. Sowers 5-Halogenated pyrimidine lesions within a CpG sequence context mimic 5-methylcytosine by enhancing the binding of the methyl-CpG-binding domain of methyl-CpG-binding protein 2 (MeCP2) Nucleic Acids Res., May 25, 2005; 33(9): 3057 - 3064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. K.Y. Chan, U.-S. Khoo, K. Y.K. Chan, H. Y.S. Ngan, S.-S. Li, P.-M. Chiu, L.-S. Man, P. P.C. Ip, W.-C. Xue, and A. N.Y. Cheung Promoter Methylation and Differential Expression of {pi}-Class Glutathione S-Transferase in Endometrial Carcinoma J. Mol. Diagn., February 1, 2005; 7(1): 8 - 16. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Zha and W. B. Isaacs A Nonclassic CCAAT Enhancer Element Binding Protein Binding Site Contributes to {alpha}-Methylacyl-CoA Racemase Expression in Prostate Cancer Mol. Cancer Res., February 1, 2005; 3(2): 110 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Nelson Prostate Cancer Prevention J. Nutr., November 1, 2004; 134(11): 3211S - 3212S. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Trzeciak, S. G. Nyaga, P. Jaruga, A. Lohani, M. Dizdaroglu, and M. K. Evans Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145 Carcinogenesis, August 1, 2004; 25(8): 1359 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. V. Tricoli, M. Schoenfeldt, and B. A. Conley Detection of Prostate Cancer and Predicting Progression: Current and Future Diagnostic Markers Clin. Cancer Res., June 15, 2004; 10(12): 3943 - 3953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Inflammation, Dietary Carcinogens, Glutathione S-Transferase {pi}, and Prostatic Carcinogenesis: WILLIAM G. NELSON, ANGELO M. DE MARZO, THEODORE L. DEWEESE, AND WILLIAM B. ISAACS, The Departments of Oncology, Urology, Pathology, Pharmacology, and Medicine, The Johns Hopkins University School of Medicine, and The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland Toxicol Pathol, January 1, 2004; 32(1): 143 - 144. [PDF]
|
|
|
|
|
|
S. Zha, S. Ferdinandusse, S. Denis, R. J. Wanders, C. M. Ewing, J. Luo, A. M. De Marzo, and W. B. Isaacs {alpha}-Methylacyl-CoA Racemase as an Androgen-Independent Growth Modifier in Prostate Cancer Cancer Res., November 1, 2003; 63(21): 7365 - 7376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakayama, C. J. Bennett, J. L. Hicks, J. I. Epstein, E. A. Platz, W. G. Nelson, and A. M. De Marzo Hypermethylation of the Human Glutathione S-Transferase-{pi} Gene (GSTP1) CpG Island Is Present in a Subset of Proliferative Inflammatory Atrophy Lesions but Not in Normal or Hyperplastic Epithelium of the Prostate: A Detailed Study Using Laser-Capture Microdissection Am. J. Pathol., September 1, 2003; 163(3): 923 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.A. Schulz, M. Burchardt, and M.V. Cronauer Molecular biology of prostate cancer Mol. Hum. Reprod., August 1, 2003; 9(8): 437 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Nelson, A. M. De Marzo, and W. B. Isaacs Prostate Cancer N. Engl. J. Med., July 24, 2003; 349(4): 366 - 381. [Full Text] [PDF]
|
|
|
|
 |
|
 I. V. Litvinov, A. M. De Marzo, and J. T. Isaacs Is the Achilles' Heel for Prostate Cancer Therapy a Gain of Function in Androgen Receptor Signaling? J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 2972 - 2982. [Full Text] [PDF]
|
|
|
|
|
|
M. L. Gonzalgo, C. P. Pavlovich, S. M. Lee, and W. G. Nelson Prostate Cancer Detection by GSTP1 Methylation Analysis of Postbiopsy Urine Specimens Clin. Cancer Res., July 1, 2003; 9(7): 2673 - 2677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. SMIRAGLIA and C. PLASS The Development of CpG Island Methylation Biomarkers Using Restriction Landmark Genomic Scanning Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 110 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. MOORE, W.-Y. HUANG, J. CHUNG, and R. B. HAYES Epidemiologic Considerations to Assess Altered DNA Methylation from Environmental Exposures in Cancer Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 181 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. VERMA, B. K. DUNN, S. ROSS, P. JAIN, W. WANG, R. HAYES, and A. UMAR Early Detection and Risk Assessment Proceedings and Recommendations from the Workshop on Epigenetics in Cancer Prevention Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 298 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lin and W. G. Nelson Methyl-CpG-binding Domain Protein-2 Mediates Transcriptional Repression Associated with Hypermethylated GSTP1 CpG Islands in MCF-7 Breast Cancer Cells Cancer Res., January 15, 2003; 63(2): 498 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Meeker, J. L. Hicks, E. A. Platz, G. E. March, C. J. Bennett, M. J. Delannoy, and A. M. De Marzo Telomere Shortening Is an Early Somatic DNA Alteration in Human Prostate Tumorigenesis Cancer Res., November 15, 2002; 62(22): 6405 - 6409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Brooks, M. F. Goldberg, L. A. Nelson, D. Wu, and W. G. Nelson Identification of Potential Prostate Cancer Preventive Agents through Induction of Quinone Reductase in Vitro Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 868 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bakker, X. Lin, and W. G. Nelson Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated pi -Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells J. Biol. Chem., June 14, 2002; 277(25): 22573 - 22580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. G. NELSON, A. M. DE MARZO, T. L. DEWEESE, X. LIN, J. D. BROOKS, M. J. PUTZI, C. P. NELSON, J. D. GROOPMAN, and T. W. KENSLER Preneoplastic Prostate Lesions: An Opportunity for Prostate Cancer Prevention Ann. N.Y. Acad. Sci., December 1, 2001; 952(1): 135 - 144. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
